Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (4): 18-24.doi: 10.6040/j.issn.1673-3770.1.2019.039

• Reseach Progress • Previous Articles     Next Articles

Progress in clinical research on circulating tumor cells in squamous cell carcinoma of the head and neck

Kun LIU,Xinxin ZHANG*()   

  1. Department of Otorhinolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2019-06-10 Online:2019-07-16 Published:2019-07-22
  • Contact: Xinxin ZHANG E-mail:xinxinzhang66@hotmail.com

RichHTML

7

PDF (PC)

473

Abstract:

Circulating tumor cells (CTCs), as one of the materials of "liquid biopsy, " have important guiding roles in the early diagnosis of head and neck squamous cell carcinoma, judgment of prognosis and therapeutic response, and monitoring of tumor recurrence and metastasis. In this paper, the progress in research on CTCs in recent years and their clinical application in head and neck squamous cell carcinoma are reviewed

Key words: Circulating tumor cells, Head and neck neoplasms, Neoplasms, squamous cell, Clinical laboratory techniques

CLC Number: 

  • R739.6
1 Jatana KR , Balasubramanian P , Lang JC , et al. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results[J]. Arch Otolaryngol Head Neck Surg, 2010, 136 (12): 1274- 1279.
doi: 10.1001/archoto.2010.223
2 Fanelli MF , Oliveira TB , Braun AC , et al. Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-β receptor I in head and neck cancer[J]. Head Neck, 2017, 39 (11): 2283- 2292.
doi: 10.1002/hed.24899
3 Economopoulou P , Kotsantis I , Kyrodimos E , et al. Liquid biopsy: an emerging prognostic and predictive tool in head and neck squamous cell carcinoma (HNSCC). focus on circulating tumor cells (CTCs)[J]. Oral Oncol, 2017, 74: 83- 89.
doi: 10.1016/j.oraloncology.2017.09.012
4 Michiels S , Le Ma tre A , Buyse M , et al. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data[J]. Lancet Oncol, 2009, 10 (4): 341- 350.
doi: 10.1016/S1470-2045(09)70023-3
5 Pignon JP , le Ma tre A , Maillard E , et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients[J]. Radiother Oncol, 2009, 92 (1): 4- 14.
doi: 10.1016/j.radonc.2009.04.014
6 Pajonk F , Schlessmann S , Guttenberger R , et al. Epithelial cells in the peripheral blood of patients with cancer of the head and neck: incidence, detection and possible clinical significance[J]. Radiother Oncol, 2001, 59 (2): 213- 217.
doi: 10.1016/S0167-8140(00)00315-7
7 Partridge M , Brakenhoff R , Phillips E , et al. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure[J]. Clin Cancer Res, 2003, 9 (14): 5287- 5294.
8 Buglione M , Grisanti S , Almici C , et al. Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival[J]. Eur J Cancer, 2012, 48 (16): 3019- 3026.
doi: 10.1016/j.ejca.2012.05.007
9 Hristozova T , Konschak R , Budach V , et al. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers[J]. Cytometry A, 2012, 81 (6): 489- 495.
doi: 10.1002/cyto.a.22041
10 Tinhofer I , Hristozova T , Stromberger C , et al. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck[J]. Int J Radiat Oncol Biol Phys, 2012, 83 (5): e685- e690.
doi: 10.1016/j.ijrobp.2012.02.009
11 Bozec A , Ilie M , Dassonville O , et al. Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma[J]. Eur Arch Otorhinolaryngol, 2013, 270 (10): 2745- 2749.
doi: 10.1007/s00405-013-2399-y
12 Gr?be A , Blessmann M , Hanken , et al. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity[J]. Clin Cancer Res, 2014, 20 (2): 425- 433.
doi: 10.1158/1078-0432.CCR-13-1101
13 Jatana KR , Balasubramanian P , McMullen KP , et al. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology[J]. Head Neck, 2016, 38 (12): 1799- 1803.
doi: 10.1002/hed.24519
14 Guney K , Yoldas B , Ozbilim G , et al. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?[J]. Saudi Med J, 2007, 28 (2): 216- 220.
15 Hristozova T , Konschak R , Stromberger C , et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)[J]. Ann Oncol, 2011, 22 (8): 1878- 1885.
doi: 10.1093/annonc/mdr130
16 He S , Li P , He S , et al. Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results[J]. J Laryngol Otol, 2013, 127 (8): 788- 793.
doi: 10.1017/S0022215113001412
17 Wollenberg B , Walz A , Kolbow K , et al. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN[J]. Onkologie, 2004, 27 (4): 358- 362.
doi: 10.1159/000079088
18 Wang ZD , Cui K , Xue Y , et al. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis[J]. Med Oncol, 2015, 32 (5): 164.
doi: 10.1007/s12032-015-0579-x[PubMed
19 Tinhofer I , Konschak R , Stromberger C , et al. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck[J]. Ann Oncol, 2014, 25 (10): 2042- 2047.
doi: 10.1093/annonc/mdu271
20 Tseng C, Lin H, Hsieh C, et al. Abstract 4830: Prognostic value of circulating tumor cells with podoplanin expression in locally advanced and metastatic head and neck squamous cell carcinoma[C]//Tumor Biology, American Association for Cancer Research, 2014. doi: 10.1158/1538-7445.am2014-4830
21 Pailler E , Oulhen M , Billiot F , et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells[J]. BMC Cancer, 2016, 16: 477.
doi: 10.1186/s12885-016-2461-4
22 Pantel K , Alix-Panabières C . Liquid biopsy: potential and challenges[J]. Mol Oncol, 2016, 10 (3): 371- 373.
doi: 10.1016/j.molonc.2016.01.009
23 Joosse SA , Gorges TM , Pantel K . Biology, detection, and clinical implications of circulating tumor cells[J]. EMBO Mol Med, 2015, 7 (1): 1- 11.
doi: 10.15252/emmm.201303698
24 Thiele JA , Bethel K , Králí?ková M , et al. Circulating tumor cells: fluid surrogates of solid tumors[J]. Annu Rev Pathol, 2017, 12: 419- 447.
doi: 10.1146/annurev-pathol-052016-100256
25 Smerage JB , Barlow WE , Hortobagyi GN , et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500[J]. J Clin Oncol, 2014, 32 (31): 3483- 3489.
doi: 10.1200/JCO.2014.56.2561
26 de Bono JS , Scher HI , Montgomery RB , et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer[J]. Clin Cancer Res, 2008, 14 (19): 6302- 6309.
doi: 10.1158/1078-0432.CCR-08-0872
27 Cohen SJ , Punt CJ , Iannotti N , et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer[J]. J Clin Oncol, 2008, 26 (19): 3213- 3221.
doi: 10.1200/JCO.2007.15.8923
28 Ignatiadis M , Lee M , Jeffrey SS . Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility[J]. Clin Cancer Res, 2015, 21 (21): 4786- 4800.
doi: 10.1158/1078-0432.CCR-14-1190
29 Gorges TM , Tinhofer I , Drosch M , et al. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition[J]. BMC Cancer, 2012, 12: 178.
doi: 10.1186/1471-2407-12-178
30 Chaffer CL , Weinberg RA . A perspective on cancer cell metastasis[J]. Science, 2011, 331 (6024): 1559- 1564.
doi: 10.1126/science.1203543
31 Kalluri R , Weinberg RA . The basics of epithelial-mesenchymal transition[J]. J Clin Invest, 2009, 119 (6): 1420- 1428.
doi: 10.1172/JCI39104
32 Puram SV , Tirosh I , Parikh AS , et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer[J]. Cell, 2017, 171 (7): 1611- 1624.
doi: 10.1016/j.cell.2017.10.044
33 Bilkenroth U , Taubert H , Riemann D , et al. Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation[J]. Int J Cancer, 2001, 92 (4): 577- 582.
doi: 10.1002/ijc.1217
34 Ozkumur E , Shah AM , Ciciliano JC , et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells[J]. Sci Transl Med, 2013, 5 (179): 179r.
doi: 10.1126/scitranslmed.3005616
35 Campton DE , Ramirez AB , Nordberg JJ , et al. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining[J]. BMC Cancer, 2015, 15: 360.
doi: 10.1186/s12885-015-1383-x
36 De Luca F , Rotunno G , Salvianti F , et al. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer[J]. Oncotarget, 2016, 7 (18): 26107- 26119.
doi: 10.18632/oncotarget.8431
37 Ulrich H , Tárnok A . Flow cytometry detection of circulating tumor cells: achievements and limitations as prognostic parameters[J]. Cytometry A, 2014, 85 (3): 201- 202.
doi: 10.1002/cyto.a.22441
38 Lu NN , Xie M , Wang J , et al. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells[J]. ACS Appl Mater Interfaces, 2015, 7 (16): 8817- 8826.
doi: 10.1021/acsami.5b01397
39 Grimwade LF , Fuller KA , Erber WN . Applications of imaging flow cytometry in the diagnostic assessment of acute leukaemia[J]. Methods, 2017, 112: 39- 45.
doi: 10.1016/j.ymeth.2016.06.023
40 Ang KK , Berkey BA , Tu XY , et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma[J]. Cancer Res, 2002, 62 (24): 7350- 7356.
41 Butt AQ , Mills KH . Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines[J]. Oncogene, 2014, 33 (38): 4623- 4631.
doi: 10.1038/onc.2013.4321
42 Kallergi G , Agelaki S , Kalykaki A , et al. Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients[J]. Breast Cancer Res, 2008, 10 (5): R80.
doi: 10.1186/bcr2149
43 Mazel M , Jacot W , Pantel K , et al. Frequent expression of PD-L1 on circulating breast cancer cells[J]. Mol Oncol, 2015, 9 (9): 1773- 1782.
doi: 10.1016/j.molonc.2015.05.009
44 Grünwald V , Keilholz U , Boehm A , et al. TEMHEAD: a single-arm multicentre phase Ⅱ study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)[J]. Ann Oncol, 2015, 26 (3): 561- 567.
doi: 10.1093/annonc/mdu571
45 Soulières D , Faivre S , Mesía R , et al. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial[J]. Lancet Oncol, 2017, 18 (3): 323- 335.
doi: 10.1016/S1470-2045(17)30064-5
46 Bauman JE , Cohen E , Ferris RL , et al. Immunotherapy of head and neck cancer: emerging clinical trials from a national cancer institute head and neck cancer steering committee planning meeting[J]. Cancer, 2017, 123 (7): 1259- 1271.
doi: 10.1002/cncr.30449
47 Li J , Shayan G , Avery L , et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk[J]. Oncoimmunology, 2016, 5 (10): e1200778.
doi: 10.1080/2162402X.2016.1200778
48 Kansy BA , Concha-Benavente F , Srivastava RM , et al. PD-1 status in CD8+ T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer[J]. Cancer Res, 2017, 77 (22): 6353- 6364.
doi: 10.1158/0008-5472.CAN-16-3167
49 Nicolazzo C , Raimondi C , Mancini M , et al. Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab[J]. Sci Rep, 2016, 6: 31726.
doi: 10.1038/srep31726
50 Kulasinghe A , Perry C , Kenny L , et al. PD-L1 expressing circulating tumour cells in head and neck cancers[J]. BMC Cancer, 2017, 17 (1): 333.
doi: 10.1186/s12885-017-3316-3
51 Oliveira-Costa JP , de Carvalho AF , da Silveira da GG , et al. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells[J]. Oncotarget, 2015, 6 (25): 20902- 20920.
doi: 10.18632/oncotarget.3939
52 Aceto N , Bardia A , Miyamoto DT , et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis[J]. Cell, 2014, 158 (5): 1110- 1122.
doi: 10.1016/j.cell.2014.07.013
53 Braig F , Voigtlaender M , Schieferdecker A , et al. Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma[J]. Oncotarget, 2016, 7 (28): 42988- 42995.
doi: 10.18632/oncotarget.8943
[1] LUO Tongyong, YANG Huaqing, YUE Shengqing, JIA Quanfan, YUAN Long. Panitan single resistance and taxol as the first-line treatment of recurrent or metastatic head and neck cancer: a phase Ⅱ study [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 71-75.
[2] Yujie SHEN,Liqing ZHANG,Han ZHOU,Qing ZHAO,Jian FENG,Shenghua SONG,Weida DONG. Clinical analysis of 34 cases of cervical lipoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 111-115.
[3] Xi CHEN,Mingzhe QIAO. Progress of immune checkpoint inhibitors in the treatment of recurrent or metastatic head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 42-48.
[4] WEI Dongmin, LI Wenming, QIAN Ye, LIU Dayu, LEI Dapeng, PAN Xinliang. Lateral neck dissection [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 115-115.
[5] WANG Bao-xin, DONG Pin, XIE Fang, DING Jian, SHEN Bin. Surgical treatment of 46 cervical neurilemmoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(4): 65-66.
[6] HUANG Fang,ZHU Cong-yue . Expression and significance of p21, p73 and PTEN in multiple primary cancers of the head and neck [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(5): 388-392 .
[7] CHEN Zhi-jun,MU Ying-xin,WANG Ping . C-reactive protein level of patients with head and neck tumor before operation [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(4): 357-359 .
[8] HUANG Yong-jiu,BAO Xue-li,KONG Xu-hui,WU Jiang,MAO Ming-rong,CHU Jiu-sheng,WANG Yu,DONG Pin . High negative pressure drainage for chylous fistula after neck dissection [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(2): 168-170 .
[9] HUANG Yong-jiu,BAO Xue-li,KONG Xu-hui,WU Jiang,MAO Ming-rong,CHU Jiu-sheng,WANG Yu,DONG Pin . High negative pressure drainage for chylous fistula after neck dissection [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(2): 168-170 .
[10] YU Zi-wei,DONG Pin,LI Xiao-yan,Amanda Psyrri,Paul Weinberger . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(5): 391-396 .
[11] ZHU Cong-yue,HuangFang . Combined expression of p21, p73 and PTEN in diagnosis of multiple primary cancers of head and neck [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(4): 352-354 .
[12] LIN Hai,ZHEN Zenian,ZHAO Min,YUAN Youwen,YANG Fuwen . Evaluation and operative approaches to tumor in parapharyngeal space:with a report of 46 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 63-64 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] YANG Changliang,HUANG Zhiwu,YAO Hangqi,ZHU Yong,SNU Yi . Study on auditory brainstem response[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 9 -13 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 89 -89 .
[3] LIU Da-yu,PAN Xin-liang,LEI Da-peng,ZHANG Li-qiang,LUAN Xin-yong . Surgical treatment for medial wall pyriform sinus cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 8 -11 .
[4] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(2): 188 -188 .
[5] LIU Yan,LIU Xin-yi,WANG Jin-ping,LI Da-jian . Measurement of the posterior tympanum and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 218 -221 .
[6] ZHAO Min,WANG Shou-sen,ZHEN Ze-nian,CHEN Xian-ming,WANG Mao-xin . Sphenoid sinus and trans-sphenoid surgery under nasal endoscopy and microscopy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 244 -245 .
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 252 -252 .
[8] WANG Hong-xia,WANG Peng-cheng . Expression of NSE,S100 and GFAP in retinoblastoma and its clinical significance[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 263 -264 .
[9] HUANG Fang,HUANG Hai-qiong,HUANG Jian-qiang,HE He-fan . Bronchoscopic video supervision system in infant bronchial foreign bodies[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 276 -277 .
[10] YU Zhi-liang,WANG Wei-wei,WANG Ming-hua . Excision of huge epiglottis cysts under MedtrnicXPS3000 in 23 cases[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 278 -279 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd